Use of rituximab in paediatric nephrology

Rituximab is a chimeric monoclonal antibody capable of depleting B cell populations by targeting the CD20 antigen expressed on the cell surface. Its use in oncology, initially in B cell lymphoma and post-transplant lymphoproliferative disorders, predates its current utility in various fields of medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Rajiv, Agrawal, Nirav, Xue, Yuanxin, Chanchlani, Rahul, Pradhan, Subal, Raina, Rupesh, Marks, Stephen D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543203/
https://www.ncbi.nlm.nih.gov/pubmed/34112638
http://dx.doi.org/10.1136/archdischild-2020-321211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543203/
https://www.ncbi.nlm.nih.gov/pubmed/34112638
http://dx.doi.org/10.1136/archdischild-2020-321211

Ejemplares similares